Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 60

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 60
---
 In determining to approve the terms of this separation and release agreement, including the additional equity acceleration and extended stock option exercise period, the Committee took into account that the separation and release agreement (i) required Ms. Elting to comply with certain post-closing restrictive covenants, and that her severance payment would not be made until 6 months following separation and would be subject to compliance with such covenants, and (ii) contained a general release of claims. In addition, the Committee took into account that, upon the departure of the Company’s prior interim Chief Legal Officer in November 2024, Ms. Elting had fulfilled the interim Chief Legal Officer function until April 2024, while also serving as the Company’s President, Orthopedics. The Committee also noted Ms. Elting’s important role in helping to integrate new leadership team members during the first half of 2024, and her continuing and ongoing cooperation with the Company with various transition activities related to the Orthopedics business unit and legal department. The amounts shown as granted on June 18, 2024 reflect the awards previously granted in 2023 and 2024 that were subject to modification. The amounts shown in the grant date fair value column reflect the incremental fair value recognized by the Company in 2024 in connection with the modification of such awards.

<div align='center'>50</div>

| OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END |

The following table provides information about the number of outstanding equity awards held by our named executive officers at December 31, 2024.

| Option Awards                            
 Name                                     
 Active Officers as of December 31, 2024: | Number of      
 Securities     
 Underlying     
 Unexercised    
 Options (#)    
 Exercisable(1) |        |     | Number of        
 Securities       
 Underlying       
 Unexercised      
 Options (#)      
 Unexercisable(2) |         |     |     | Option   
 Exercise 
 Price    
 ($)      |       |     | Option     
 Expiration 
 Date       |   |     | Stock Awards 
 Number       
 of Shares    
 or Units of  
 Stock that   
 have not     
 Vested (#)   |        |     |     | Market      
 Value       
 of Shares   
 or Units of 
 Stock that  
 have not    
 Vested ($)  |           |     | Equity Incentive Plan Awards: Number                     
 of Unearned Shares, Units or Other Rights  that have not 
 Vested (#)                                               |